The Cooper Companies, Inc.
General ticker "COO" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $14.3B (TTM average)
The Cooper Companies, Inc. does not follow the US Stock Market performance with the rate: -17.7%.
Estimated limits based on current volatility of 1.7%: low 55.21$, high 57.49$
Factors to consider:
- Company included in S&P500 list
- Total employees count: 15000 (-6.2%) as of 2025
- US accounted for 50.2% of revenue in the fiscal year ended 2025-10-31
- Top business risk factors: Economic downturns and volatility, Operational and conduct risks, Geopolitical risks, Regulatory and compliance, Acquisition/divestiture risks
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-10-31 to 2027-10-31
- 2025-10-31 to 2026-10-31 estimated range: [58.14$, 84.67$]
- 2026-10-31 to 2027-10-31 estimated range: [61.52$, 88.40$]
Financial Metrics affecting the COO estimates:
- Negative: with PPE of 17.5 at the end of fiscal year the price was high
- Positive: -2.60 < Investing cash flow per share per price, % of -2.57
- Positive: 15.80 < Operating profit margin, % of 16.69
- Positive: 1.88 < Return on assets ratio (scaled to [-100,100]) of 2.94
- Positive: 4.90 < Operating cash flow per share per price, % of 5.50
- Negative: Industry inventory ratio change (median), % of 1.73 > 1.15
- Negative: Industry earnings per price (median), % of 0 <= 0
- Negative: negative Industry operating income (median)
- Positive: 0.90 < Industry operating cash flow per share per price (median), % of 1.48
- Negative: 58.56 < Shareholder equity ratio, % of 66.47 <= 69.38
Short-term COO quotes
Long-term COO plot with estimates
Financial data
| YTD | 2023-10-31 | 2024-10-31 | 2025-10-31 |
|---|---|---|---|
| Operating Revenue | $3,593.20MM | $3,895.40MM | $4,092.40MM |
| Operating Expenses | $3,060.10MM | $3,189.70MM | $3,409.50MM |
| Operating Income | $533.10MM | $705.70MM | $682.90MM |
| Non-Operating Income | $-120.20MM | $-123.40MM | $-116.40MM |
| Interest Expense | $105.30MM | $114.30MM | $100.00MM |
| R&D Expense | $137.40MM | $155.10MM | $172.20MM |
| Income(Loss) | $412.90MM | $582.30MM | $566.50MM |
| Taxes | $118.70MM | $190.00MM | $191.60MM |
| Net Income(Loss)* | $294.20MM | $392.30MM | $374.90MM |
| Stockholders Equity | $7,550.80MM | $8,083.40MM | $8,238.90MM |
| Inventory | $735.60MM | $802.70MM | $846.00MM |
| Assets | $11,658.90MM | $12,315.20MM | $12,394.80MM |
| Operating Cash Flow | $607.50MM | $709.30MM | $796.10MM |
| Capital expenditure | $392.50MM | $421.20MM | $362.40MM |
| Investing Cash Flow | $-449.00MM | $-764.60MM | $-372.90MM |
| Financing Cash Flow | $-173.90MM | $39.20MM | $-425.90MM |
| Earnings Per Share** | $1.49 | $1.97 | $1.87 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.